Anzeige
Erschienen in:
21.09.2016 | Original Article
Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV
Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2017
Einloggen, um Zugang zu erhaltenAbstract
Background
Medical comorbidities and functional status limitations are determinants of mortality in many chronic diseases. The extent to which survival in the rapidly aging cohort of patients with HCV is affected by these competing causes of mortality remains unclear.
Aim
We sought to determine the effect of medical/functional comorbidities on survival after adjusting for liver disease severity in a cohort of patients with HCV infection.
Methods
We prospectively recruited consecutive patients from an HCV clinic 2009–2014. We calculated an index of survival (Schonberg Index, SI) based on age, gender, medical comorbidities, and functional status variables. We defined cirrhosis with the FibroSure test (F3/4–F4). We used multivariable Cox modeling to assess association between functional/survival measure and survival after adjustment for severity of liver disease.
Results
The cohort consisted of 1052 HCV patients. The average age was 56.8 years; 36 % had cirrhosis. The mean SI was 8.2 (SD = 2.7). During a mean follow-up of 5610 person-years, 102 (9.7 %) patients died. In unadjusted analysis, higher baseline SI predicted mortality (HR 1.17; 95 % CI 1.09–1.25). SI similarly predicted mortality in cirrhotic patients (HR 1.23, 95 % CI 1.13–1.34) and non-cirrhotic patients (HR 1.21, 95 % CI 1.08–1.36). This did not change after adjusting for age, drug use, or coronary artery disease.
Discussion
Comorbidities and functional limitations predict higher mortality in patients with HCV; this relationship is independent of cirrhosis. Use of general prognostic indices may help identify HCV patients at high risk for mortality, which could further guide clinical care in a manner not achievable with assessment of liver disease alone.